Michelle B. Atallah, an Arab American of Palo Alto, California, is making waves in the Cancer Biology Ph.D. program at Stanford University. She is currently designing algorithms to identify mechanisms in tumor-driven immunosuppression. Utilizing a new technology called Multiplexed Ion beam Imaging, she is collecting data about immune cells within tumors in order to better apply therapeutic intervention. ^{[22] [27] [7]} Also, Ms. Atallah is the Member of the Society for Immunotherapy of Cancer and the Director of Client Relations and Senior College Consultant at Cortex College Consulting. ^{[23] [24]}

Michelle Atallah received her Bachelor's degree in Molecular, Cellular, and Developmental Biology from Yale University in 2012, where she enrolled in 2008. ^[23] While studying there, Michelle was awarded various grants and awards, such as Sherwood E. Silliman Fellowship for Research in the Natural Sciences, Yale University (2010), Yale Science and Engineering Association Undergraduate Research Grant, Yale University (2011), Silliman Mellon Grant for Undergraduate Theses, Yale University (2011), Richter Summer Fellowship, Yale University (2011), NORD/DIA Student Presenter Travel Award, National Organization of Rare Diseases (2012), and Helzer Travel Grant, Yale University (2012). ^[24] She also was actively involved in university activities and societies like being a Science and Engineering Ambassador, Chair of Silliman Intercultural Affairs Committee; Member of Silliman Seminar Selection Committee; Tutor and Interpreter in the Yale Refugee Project. In 2014 Michelle Atallah graduated from Stanford University and earned her Ph.D. in Cancer Biology. During her postgraduate studies, Michelle was a Member of the Mallick and Engleman Labs at Stanford University. ^[23] In addition, she won the NORD/DIA Patient Advocate Scholarship by the National Organization of Rare Diseases in 2013 and the Graduate Research Fellowship by National Science Foundation in 2015. ^{[23] [24]}

Michelle B. Atallah worked at the NameBuck Institute for Age Research from May - August 2009. As a summer research associate, she contributed to Investigation of effect of lentiviral construct on adult mesenchymal stem cell pluripotency: she optimized and ran gel electrophoresis and Northern blots with Xray detection to determine level of knockout of repetitive DNA sequences, and performed immunofluorescence to evaluate proliferation activity of infected cells. During the period of May - August 2010, Ms. Atallah worked as a summer research associate at the Namebuck Institute again. This time she designed PCR primers for various genes and differentiation markers and used qPCR to investigate the level of gene expression of several genes in adult mesenchymal stem cells of various ages. ^[23]From June 2011 to August of the same year Michelle was employed at Accenture, Greece, where being a Management Consulting and Systems Integration Intern where she ran systems tests, prepared training materials for defect management, documented the preparation of deliverables, and researched for and helped write the value realization plan with one of the senior project managers. ^[23]Starting from April 2011 - May 2012, she was a peer advisor at Undergraduate Career Services, Yale University. Her job at Yale included counseling students one-on-one to advise on job searches, networking, interviewing, and making the review of résumés and cover letters, etc. During her work as a clinical research associate at Nodality Inc., which lasted two years from July 2012 - July 2014, Michelle managed communications between Nodality and academic or industry collaborators, drafted clinical protocols, scientific manuscripts, and conference abstracts; and represented clinical group at Cancer Immunotherapy, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Rheumatoid Arthritis product team meetings. Furthermore, she made a supervise setup of clinical trial sites, receipt of primary samples and management of patient and disease data, evaluated patient eligibility for studies, and coordinated processing and cryopreservation of samples with the lab. ^[23]From December 2014 to May 2016, Michelle Atallah was a Director of International Pemphigus and Pemphigoid Foundation. Since August 2014, she works at the Mallick and Engleman Labs. Currently, Dr. Michelle Atallah is the Director of Client Relations and Senior College Consultant at Cortex College Consulting (since October 2016). ^[23]

*"As a Ph.D. candidate in the Cancer Biology program at Stanford, I’m working on designing algorithms to identify mechanisms of tumor-driven immunosuppression.

Using high-parameter multiplexed imaging to analyze spatial patterning and activation features of immune cells within tumors, I hope to create ways to reconstruct the intratumoral immune signaling network and identify points of therapeutic intervention.*

*I'm also a strong supporter of rare disease advocacy.

I’ve served on the board of directors of the International Pemphigus and Pemphigoid Foundation, have previously published and presented original research on Familial Mediterranean Fever disease mechanisms, and am involved with the National Organization for Rare Disorders."*

Dr. Michelle Atallah [15]

Michelle B. Atallah has a sister Loreen Atallah who is a year younger than her and a PharmD Candidate at the University of California, San Francisco. Also, Michelle is related to Bud Aziz, Hala Khouri, Josh Aziz, Ramsey B., and Waleed B. Atallah. ^{[23] [25] [1]}